Search Results - "Liver"
Suggested Topics within your search.
Suggested Topics within your search.
- Medicine 118
- Biology, life sciences 66
- Research & information: general 62
- Oncology 23
- Pharmacology 22
- Food & society 15
- Hepatology 15
- Endocrinology 14
- Surgery 14
- Technology: general issues 9
- Immunology 8
- Public health & preventive medicine 8
- Clinical & internal medicine 7
- Gastroenterology 7
- Chemistry 6
- Biotechnology 5
- General surgery 5
- Humanities 5
- Infectious & contagious diseases 5
- Social interaction 5
- Cardiovascular medicine 4
- Internal Medicine 4
- Internal medicine 4
- Medicine: general issues 4
- Physiology 4
- Biochemistry 3
- Epidemiology & medical statistics 3
- Gastrointestinal & colorectal surgery 3
- Genetics (non-medical) 3
- History of engineering & technology 3
-
18621
Antisense RNA Design, Delivery, and Analysis
Published 2022Table of Contents: “…Introduction and History of the Chemistry of Nucleic Acids Therapeutics -- Antisense RNA Therapeutics: A Brief Overview -- Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion -- Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation -- How to Design U1 snRNA Molecules for Splicing Rescue -- Conjugation of Nucleic Acids and Drugs to Gold Nanoparticles -- Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay -- Generation of Protein-Phosphorodiamidate Morpholino Oligomer Conjugates for Efficient Cellular Delivery via Anthrax Protective Antigen -- Development and Use of Cellular Systems to Assess and Correct Splicing Defects -- Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells -- In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin -- In Vitro Delivery of PMOs in Myoblasts by Electroporation -- Rapid Determination of MBNL1 Protein Levels by Quantitative Dot Blot for Evaluation of Antisense Oligonucleotides in Myotonic Dystrophy Myoblasts -- Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy -- Generation of Human iPSC-Derived Myotubes to Investigate RNA-Based Therapies In Vitro -- Eye on a Dish Models to Evaluate Splicing Modulation -- Establishment of In Vitro Brain Models for AON Delivery -- Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides -- Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies -- Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense Treatment -- In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin -- Delivery of Antisense Oligonucleotides to the Mouse Retina -- Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections -- Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System -- Preclinical Safety Assessment of Therapeutic Oligonucleotides -- Preclinical Evaluation of the Renal Toxicity of Oligonucleotide Therapeutics in Mice -- Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution -- Patent Considerations When Embarking on New Antisense Drug Programs.…”
Link to Metadata
Electronic eBook -
18622
-
18623
-
18624
-
18625
-
18626
-
18627
-
18628
-
18629
-
18630
-
18631
-
18632
-
18633
-
18634
-
18635
-
18636
-
18637
-
18638
-
18639
-
18640